HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway.

Abstract
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of hepatic abnormalities that extends from isolated steatosis to non-alcoholic steatohepatitis (NASH) and steatofibrosis. NASH is the progressive form of the disease that can lead to fibrosis, cirrhosis and hepatocellular carcinoma. Naringenin (NGEN), a healthful food, increases resistance to oxidative stress, inflammation and protects against multiple organ injury in various animal models. However, specific mechanisms responsible for such effects are poorly understood. Thus, this study investigates the effect of treatment with NGEN (50mg/kg) on oxidative events and the molecular mechanisms underlying inflammatory changes triggered in the rat liver by a high cholesterol diet for 90 days. NGEN significantly decreased the plasma fatty acid composition, the hepatic pro-inflammatory mediators and the expression of relevant genes including tumor necrosis factor-α, interlukin-6, interleukin-1β, inducible nitric oxide synthase and matrix metalloproteinases (MMP-2, 9), EGF-like module-containing mucin-like hormone receptor-like 1 (macrophage F4/80-specific gene); which suggests a reduced macrophage infiltration, and inhibited oxidative stress related biomarker levels at the end point of the experiment. Mechanistically, studies showed that NGEN markedly reduced lipid and protein oxidations, recruited the anti-oxidative defense system and promoted extracellular matrix degradation by modulating the levels of necrotic inflammation.
AuthorsYassine Chtourou, Hamadi Fetoui, Raoua Jemai, Ahlem Ben Slima, Mohamed Makni, Radhouane Gdoura
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 746 Pg. 96-105 (Jan 05 2015) ISSN: 1879-0712 [Electronic] Netherlands
PMID25446569 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Biomarkers
  • Flavanones
  • Inflammation Mediators
  • Lipids
  • NF-kappa B
  • Cholesterol
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • naringenin
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology, therapeutic use)
  • Antioxidants (pharmacology, therapeutic use)
  • Biomarkers (metabolism)
  • Body Weight (drug effects)
  • Cholesterol (adverse effects)
  • DNA Fragmentation (drug effects)
  • Down-Regulation (drug effects)
  • Flavanones (pharmacology, therapeutic use)
  • Inflammation Mediators (metabolism)
  • Lipids (blood)
  • Liver (drug effects, metabolism, pathology)
  • Male
  • Matrix Metalloproteinase 2 (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • NF-kappa B (metabolism)
  • Non-alcoholic Fatty Liver Disease (chemically induced, drug therapy, metabolism, pathology)
  • Rats
  • Rats, Wistar
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: